BIONEER CORPORATION

Bioneer Successfully Concludes Participation in ‘EADV 2024’

 

-The clinic-exclusive product CosmeRNA Intensive unveiled for the first time

-Consultations held with leading global hair specialists and professional companies at the promotional booth

-Innovative hair loss solutions showcased at EADV 2024

 

Bioneer announced on the 30th that it had successfully concluded its participation in the 2024 EADV (European Academy of Dermatology and Venereology) held from September 25 to 28 in Amsterdam, Netherlands. The company showcased its innovative hair loss cosmetic product, CosmeRNA, and its hair loss molecular diagnostic kit, attracting significant attention.

 

The 33rd EADV annual meeting is Europe’s largest event where global pharmaceutical companies and dermatologists gather to share the latest research and technologies. This year marked Bioneer’s second participation in the event, aiming to promote CosmeRNA to hair loss specialists and establish business partnerships.

 

At the exhibition, Bioneer unveiled CosmeRNA Intensive, a clinic-exclusive product, for the first time. The product garnered high interest from dermatologists and distribution partners, leading to numerous inquiries and pre-orders.

 

Bioneer also conducted live demonstrations using its IRON-qPCR™ molecular diagnostic device, which was developed over a decade. By analyzing a single hair strand, the device can quantify the expression of hair loss-related mRNA within 40 minutes, making it the first of its kind to offer molecular diagnostics for hair loss. Dermatology specialists expressed amazement at the innovation and showed interest in incorporating the technology into their clinics.

 

The company highlighted its development of CosmeRNA ARI, which reduces the mRNA expression of androgen receptors in hair follicles. This product won the Hair Product of the Year award at the Cosmoprof Awards 2024, the world’s largest cosmetics exhibition, where it demonstrated an 80–90% response rate for androgenic alopecia. It is now being sold globally as one of the most innovative cosmetics.

 

Hair loss can result from various causes beyond androgen factors, leading to diverse mRNA changes in hair follicle cells. Bioneer’s ability to quantify hair loss-related mRNA in 40 minutes offers the potential to standardize molecular diagnostics for hair loss in global clinics.

Looking ahead, Bioneer plans to develop a portfolio of CosmeRNA products targeting major hair loss-related mRNAs while supplying diagnostic equipment to global markets. By integrating molecular diagnostics with customized cosmetics targeting hair loss-inducing mRNA, the company aims to pioneer a new paradigm for hair loss management. This innovative approach has garnered significant praise from specialists worldwide.

 

A company representative stated, “With CosmeRNA’s proven safety and convenience, we are working with global dermatologists, professors, and experts to establish a new paradigm in hair loss molecular diagnostics and personalized management. Following connections made at this event, we plan to expand international sales channels and focus on advancing on-site molecular diagnostics and CosmeRNA products addressing diverse hair loss causes.”